University of Oslo scientists identified a panel of four microRNAs that can distinguish between heart failure types and ...
Alzheimer’s disease (AD) accounts for 60–80% of all dementia cases, with women at higher risk due to both longevity and biological factors. Familial AD, ...
Causeway Therapeutics, a clinical-stage biotechnology company developing novel medicines for tendon disease, today announced positive topline data from its Phase 2 clinical trial evaluating TenoMiR ® ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback